Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Transgene and ProBioGen Enter License Agreement for Individualized Cancer Vaccine Development

Nov 05, 2024•almost 2 years ago

Contract Type

partnership

Bas-RhinBiotechnologyHealth CareTherapeutics

Description

Transgene and ProBioGen have entered into a partnership to advance individualized cancer vaccine development. The collaboration aims to combine ProBioGen's specific production technology with Transgene's individualized cancer vaccine program and its myvac® platform.

Company Information

Company

Transgene

Location

Bas-Rhin, Grand Est, France

About

Transgene is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. The Company’s clinical-stage programs consist of a portfolio of therapeutic vaccines and oncolytic viruses with the goal of indirectly or directly killing cancer cells.

Related People

Suggested for you
James
Likely contact at this company
••••••••@••••••••

See James's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Transgene's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Transgene signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.